Catalyst Wire Dossier Catalyst Wire Dossier

Latrepirdine

latrepirdine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Latrepirdine, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia [Phase 3]

See pricing